Replies to post #621999 on NorthWest Biotherapeutics Inc (NWBO)

[DrHigh]

If we are paying Advent/Toucan directly in stock, I fear due dates for bills/milestones to be paid are driving when we pull the trigger on submission or just flat out communicating. Toucan doesn't want to get paid in stock with a $5+ stock price when they could get paid in the 40 cent or lower range. The conflicts of interest need to be removed asap for the sake of cancer patients and investors IMO.

[Poor Man -]

This might be a question for both you and FeMike. But in your experience, what are the possible reasons for such a lengthy delay in submitting the UK application? Is there any real benefit for waiting until Flashworks is fully optimized and operational? Can’t the amended manufacturing license be handled separately from the approval process for the vaccine?

Complete mystery to how this is being handled by management, and enormously destructive to shareholder value. I just came back from lunch and the stock is now trading at 45 cents per share.

[CrashOverride]

If regulators are holding up submission, for reasons such as flaws in the product or trial design, it would be fraud for management to not make this disclosure.

The law has no ambiguity on this matter.

They haven't done so because no such regulatory concern exists. Of course you frame this all in the most negative way possible by suggesting management are criminals.

Gaslighting.